Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

Air Displacement Pipettors Empower a New Line of Microbiology Diagnostic Instruments

By BiotechDaily International staff writers
Posted on 23 Dec 2013
Image: The new Cavro Air Displacement Pipettor (ADP) is a compact, pneumatic pipetting solution for easy integration and exceptional liquid handling performance (Photo courtesy of Tecan).
Image: The new Cavro Air Displacement Pipettor (ADP) is a compact, pneumatic pipetting solution for easy integration and exceptional liquid handling performance (Photo courtesy of Tecan).
Image: Cavro ADP modules in the PRELUD instrument enables accurate liquid dispensing ranging from microliters to milliliters (Photo courtesy of Tecan).
Image: Cavro ADP modules in the PRELUD instrument enables accurate liquid dispensing ranging from microliters to milliliters (Photo courtesy of Tecan).
A French manufacturer of microbiology diagnostic instruments had incorporated Swiss-built air displaced pipette units in its new line of liquid handling systems.

Tecan (Männedorf, Switzerland), a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics recently announced that the French microbiological instrument manufacturer i2a (Montpellier, France) would be incorporating its Cavro Air Displacement Pipettor (ADP) into PRELUD, an automated preanalytical instrument for the inoculation of culture plates and preparation of agar susceptibility tests.

The Cavro ADP is a fully programmable pneumatic pipetting module that uses air rather than liquid displacement to aspirate and dispense fluids. The slender design allows the Cavro ADP to be mounted in automated applications with narrow 18 mm spacing between devices. The Cavro ADP is compatible with Tecan’s high quality disposable tips (DiTis) for situations where washing tips between samples is ineffective or impractical.

“We needed something very light and easy to use, and that was capable of pipetting liquid volumes ranging from microliters to milliliters,” said Michel Roch, i2a's PRELUD project manager. “The Cavro ADP was easy to integrate because it operates mechanically without the use of liquids, and it allows precision liquid dispensing. The tip ejector was another highly useful function; we use Tecan’s disposable tips and simply change between 10 microliter, 200 microliter and 1 milliliter tips according to our needs. We were able to integrate the Cavro ADP into PRELUD very quickly and, within two days, we could handle liquids. The reproducibility, precision, and accuracy of the Cavro ADP are good enough for our microbiology application without the need for any further tests or trials. We are very satisfied with our collaboration with Tecan.”

Related Links:
Tecan
i2a 


comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: To adhere to catheters and start urinary tract infections, bacteria extend microscopic fibers with sticky proteins at their ends. Researchers have developed a vaccine that blocks the EbpA protein, visible as a white bulge above, and stops infections in mice (Photo courtesy of Dr. John Heuser, Washington University School of Medicine).

Blocking Binding of Bacteria to Fibrinogen Prevents Biofilm Formation and Catheter-Associated Bladder Infection in Mice

A team of molecular microbiologists has identified and targeted a critical step in biofilm formation and developed a vaccine that prevents catheter-associated urinary tract infections in mice.... Read more

Drug Discovery

view channel
Image: S-649266 has more robust antibacterial activity than established antibiotics against multidrug-resistant bacteria (Photo courtesy of Shionogi).

Novel Antibiotic Shows Potential for Broad Range of Infections

The emergence of bacterial resistance to known antibacterial agents is becoming a major challenge in treating the infection caused by multi drug resistant (MDR) bacteria. In order to treat bacterial... Read more

Business

view channel

Collaboration of Mayo Clinic and IBM Cognitive Computer Devised to Improve Clinical Trial Research

The Mayo Clinic (Rochester, MN, USA) and IBM (Armonk, NY, USA) recently announced plans to pilot Watson, the IBM cognitive computer, to match patients more rapidly with suitable clinical trials. A proof-of-concept phase is currently ongoing, with the intent to introduce it into clinical use in early 2015.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.